Measles Resurgence: Why Cases Are Rising Globally

Why Are Measles Cases Increasing Worldwide?

The World Health Organization and CDC have documented a substantial increase in global measles activity, with outbreaks reported across multiple WHO regions including Europe, the Americas, the Eastern Mediterranean, and Africa. The primary driver is a drop in routine immunization that began during the COVID-19 pandemic, when health systems were disrupted and well-child visits were postponed. Many children missed their first or second dose of measles-containing vaccine, creating large susceptible populations.

Measles is among the most contagious infectious diseases known. The basic reproduction number (R0) is estimated at 12 to 18, meaning a single infected person can transmit the virus to that many susceptible contacts in an unvaccinated population. The virus remains airborne in a room for up to two hours after an infected person has left. Because of this extreme transmissibility, even small declines in vaccination coverage can rapidly translate into outbreaks, particularly in schools, day-care centers, and densely populated communities.

How Effective Is the MMR Vaccine and Who Should Receive It?

The measles, mumps, and rubella (MMR) vaccine is one of the most effective vaccines in routine use. According to CDC data, a single dose is approximately 93% effective against measles, while two doses raise effectiveness to about 97%. Protection is generally long-lasting, and serious adverse events are rare. The standard schedule recommends a first dose at 12 to 15 months of age and a second dose at 4 to 6 years, though the second dose can be administered earlier as long as it follows the first by at least 28 days.

Public health authorities also recommend catch-up vaccination for older children, adolescents, and adults who are unvaccinated or have uncertain vaccination histories, particularly before international travel. Healthcare workers, college students, and people living in or traveling to outbreak areas are encouraged to verify their immunity. Because measles can cause severe complications including pneumonia, encephalitis, and a rare delayed neurological disease called subacute sclerosing panencephalitis, prevention through vaccination remains the cornerstone of public health response.

What Are the Symptoms and Complications of Measles?

Measles typically begins 7 to 14 days after exposure with high fever, cough, coryza (runny nose), and conjunctivitis. Tiny white spots called Koplik spots may appear inside the mouth a day or two before the rash. The hallmark red, blotchy rash usually starts on the face at the hairline and spreads downward to the trunk and limbs. Patients are infectious from approximately four days before the rash appears until four days after.

While most healthy children recover, complications occur in a meaningful fraction of cases. The CDC estimates that about 1 in 5 unvaccinated people who contract measles in the United States will be hospitalized, and roughly 1 to 3 in 1,000 children with measles will die from respiratory or neurological complications. Measles infection also causes prolonged immune suppression, sometimes called immune amnesia, which can leave survivors vulnerable to other infections for months or years afterward. These risks underscore why maintaining high vaccination coverage is essential at both the individual and community level.